CMS published the RAPID device coverage pathway on August 11, 2026. The headline: a proposed Medicare coverage decision the same day as FDA authorization. The fine print is more complicated.
Eligibility is tight. Only Breakthrough devices at the pre-submission stage qualify. If your study is already enrolling patients, the door is closed. In vitro diagno…
